The nation of Zimbabwe has turned down a significant American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of the United States' demand for sensitive biological samples.
This rejection became public after a official document from December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "skewed".
A government spokesman has since clarified that the United States was requesting genetic material for research and commercial purposes but was unwilling to share the benefits from any future vaccines.
"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for more dialogue to find a agreement acceptable to all parties so the country's critical HIV treatment initiative can continue.
Broader Implications
Zimbabwe's decision comes after a comparable situation in Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and responsibility.
As per statements, Sixteen nations in Africa have so far signed similar agreements, constituting over $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information for a long time, without any corresponding promise of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," Mangwana explained.
"In essence, our country would provide the basic resources for medical research without any certainty that the resulting innovations would be accessible to our people if a future disease outbreak emerge."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks already established through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to continued discussions with our US partners on how subsequent collaboration could be designed in a way that respects the sovereignty and dignity of both nations."
Health Experts Response
Medical experts said it understood the government's concerns, but urged that negotiations need to persist considering a large portion of the country's HIV programmes relied on foreign aid.
"If technical issues exist, including those relating to information security or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.
The halted deal highlights the complex challenges between receiving much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.